Literature DB >> 12477721

Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras.

Gerald V Denis1, Qiang Yu, Peihong Ma, Linda Deeds, Douglas V Faller, Chang-Yan Chen.   

Abstract

Bcl-2 protects cells against Ras-mediated apoptosis; this protection coincides with its binding to Ras. However, the protection mechanism has remained enigmatic. Here, we demonstrate that, upon apoptotic stimulation, newly synthesized Bcl-2 redistributes to mitochondria, interacts there with activated Ras, and blocks Ras-mediated apoptotic signaling. We also show, by employing bcl-2 mutants, that the BH4 domain of Bcl-2 binds to Ras and regulates its anti-apoptotic activity. Experiments with a C-terminal-truncated Ras or a farnesyltransferase inhibitor demonstrate that the CAAX motif of Ras is essential for apoptotic signaling and Bcl-2 association. The results indicate a potential mechanism by which Bcl-2 protects cells against Ras-mediated apoptotic signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12477721     DOI: 10.1074/jbc.M210202200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Bcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated Bax.

Authors:  Zhi Zhang; Suzanne M Lapolla; Matthew G Annis; Mary Truscott; G Jane Roberts; Yiwei Miao; Yuanlong Shao; Chibing Tan; Jun Peng; Arthur E Johnson; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

Review 2.  The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.

Authors:  D M D'Agostino; M Silic-Benussi; H Hiraragi; M D Lairmore; V Ciminale
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

Review 3.  Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.

Authors:  Yi-Ping Rong; Paul Barr; Vivien C Yee; Clark W Distelhorst
Journal:  Biochim Biophys Acta       Date:  2008-11-12

4.  Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis.

Authors:  Hajime Hiraragi; Bindhu Michael; Amrithraj Nair; Micol Silic-Benussi; Vincenzo Ciminale; Michael Lairmore
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells.

Authors:  D Trisciuoglio; C Gabellini; M Desideri; Y Ragazzoni; T De Luca; E Ziparo; D Del Bufalo
Journal:  Cell Death Differ       Date:  2011-01-14       Impact factor: 15.828

6.  Synaptic and non-synaptic mitochondria in hippocampus of adult rats differ in their sensitivity to hypothyroidism.

Authors:  E Zhuravliova; T Barbakadze; N Jojua; E Zaalishvili; L Shanshiashvili; N Natsvlishvili; I Kalandadze; N Narmania; I Chogovadze; D Mikeladze
Journal:  Cell Mol Neurobiol       Date:  2012-06-17       Impact factor: 5.046

7.  The oncogenic RAS2(val19) mutation locks respiration, independently of PKA, in a mode prone to generate ROS.

Authors:  Lydie Hlavatá; Hugo Aguilaniu; Alena Pichová; Thomas Nyström
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

8.  RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1.

Authors:  Xiaobo Wang; Karine Belguise; Christine F O'Neill; Nuria Sánchez-Morgan; Mathilde Romagnoli; Sean F Eddy; Nora D Mineva; Ziyang Yu; Chengyin Min; Vickery Trinkaus-Randall; Dany Chalbos; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2009-05-11       Impact factor: 4.272

Review 9.  BH4 domain of Bcl-2 as a novel target for cancer therapy.

Authors:  Zhiqing Liu; Christopher Wild; Ye Ding; Na Ye; Haiying Chen; Eric A Wold; Jia Zhou
Journal:  Drug Discov Today       Date:  2015-11-26       Impact factor: 7.851

10.  Nicotine, through upregulating pro-survival signaling, cooperates with NNK to promote transformation.

Authors:  Takashi Nishioka; Jinjin Guo; Daisuke Yamamoto; Lihua Chen; Petra Huppi; Chang Yan Chen
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.